Announcements Trials
Browse Landscape

Status

Recruiting 2Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 4Observational 3

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Breast Neoplasms 92Neoplasms 87Lung Neoplasms 55Prostatic Neoplasms 48Colorectal Neoplasms 42Carcinoma, Non-Small-Cell Lung 35Pancreatic Neoplasms 24Multiple Myeloma 24Stomach Neoplasms 21Hematologic Neoplasms 21Carcinoma, Hepatocellular 19Ovarian Neoplasms 18Melanoma 17Lymphoma 16Leukemia, Myeloid, Acute 16Esophageal Neoplasms 16Brain Neoplasms 16Urinary Bladder Neoplasms 13Liver Neoplasms 13Colonic Neoplasms 13Uterine Cervical Neoplasms 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Neoplasm Metastasis 12Leukemia, Lymphocytic, Chronic, B-Cell 12Leukemia 12Kidney Neoplasms 12Head and Neck Neoplasms 12Endometrial Neoplasms 12Disease 12Recurrence 11

Interventions

anifrolumab 1Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Infections × 30 days × Clear all
NCT07609576 2026-05-27

Infectious Complications in Hematological Patients Under Treatment With Bispecific Antibodies.

Infanta Leonor University Hospital

Recruiting
350 enrolled
Plasma cell

Infections, Multiple Myeloma

NCT07000110 2026-05-20

SIMA

AstraZeneca

Recruiting
3,195 enrolled

Infections, Lupus Erythematosus, Systemic, Neoplasms

NCT06790420 2026-05-15

RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study

Pfizer

Completed
2,703 enrolled 13 charts
Lymphoid

Infections, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡